Search Results

There are 16087 results for: content related to: Pharmacokinetics of buprenorphine following intravenous and buccal administration in cats, and effects on thermal threshold

  1. Pharmacokinetic-pharmacodynamic modelling of intravenous buprenorphine in conscious horses

    Veterinary Anaesthesia and Analgesia

    Volume 42, Issue 1, January 2015, Pages: 17–29, Emma J Love, Ludovic Pelligand, Polly M Taylor, Joanna C Murrell and John W Sear

    Version of Record online : 16 APR 2014, DOI: 10.1111/vaa.12165

  2. You have full text access to this Open Access content
    A Review of the Studies Using Buprenorphine in Cats

    Journal of Veterinary Internal Medicine

    Volume 28, Issue 3, May/June 2014, Pages: 762–770, P.V.M. Steagall, B.P. Monteiro-Steagall and P.M. Taylor

    Version of Record online : 21 MAR 2014, DOI: 10.1111/jvim.12346

  3. You have free access to this content
    Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence

    Intervention Review

    The Cochrane Library

    Richard P Mattick, Courtney Breen, Jo Kimber and Marina Davoli

    Published Online : 6 FEB 2014, DOI: 10.1002/14651858.CD002207.pub4

  4. Buprenorphine for the management of opioid withdrawal

    Intervention Review

    The Cochrane Library

    Linda Gowing, Robert Ali and Jason M White

    Published Online : 8 JUL 2009, DOI: 10.1002/14651858.CD002025.pub4

  5. You have free access to this content
    Buprenorphine for treating cancer pain

    Intervention Review

    The Cochrane Library

    Mia Schmidt-Hansen, Nathan Bromham, Mark Taubert, Stephanie Arnold and Jennifer S Hilgart

    Published Online : 31 MAR 2015, DOI: 10.1002/14651858.CD009596.pub4

  6. Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers

    Addiction

    Volume 105, Issue 4, April 2010, Pages: 709–718, Sandra D. Comer, Maria A. Sullivan, Suzanne K. Vosburg, Jeanne Manubay, Leslie Amass, Ziva D. Cooper, Phillip Saccone and Herbert D. Kleber

    Version of Record online : 10 MAR 2010, DOI: 10.1111/j.1360-0443.2009.02843.x

    Corrected by:

    Erratum

    Vol. 105, Issue 7, 1322, Version of Record online: 8 JUN 2010

  7. Buprenorphine

    Medical Toxicology of Drug Abuse: Synthesized Chemicals and Psychoactive Plants

    Donald G. Barceloux, Pages: 514–526, 2012

    Published Online : 2 FEB 2012, DOI: 10.1002/9781118105955.ch28

  8. Correlations of Maternal Buprenorphine Dose, Buprenorphine, and Metabolite Concentrations in Meconium With Neonatal Outcomes

    Clinical Pharmacology & Therapeutics

    Volume 84, Issue 5, November 2008, Pages: 604–612, SL Kacinko, HE Jones, RE Johnson, RE Choo and MA Huestis

    Version of Record online : 13 AUG 2008, DOI: 10.1038/clpt.2008.156

  9. You have free access to this content
    Buprenorphine-Based Regimens and Methadone for the Medical Management of Opioid Dependence: Selecting the Appropriate Drug for Treatment

    The American Journal on Addictions

    Volume 19, Issue 6, November-December 2010, Pages: 557–568, Icro Maremmani and Gilberto Gerra

    Version of Record online : 21 SEP 2010, DOI: 10.1111/j.1521-0391.2010.00086.x

  10. You have full text access to this OnlineOpen article
    The safety of high-dose buprenorphine administered subcutaneously in cats

    Journal of Veterinary Pharmacology and Therapeutics

    Volume 38, Issue 5, October 2015, Pages: 434–442, M. K. Sramek, M. C. Haas, G. D. Coleman, P. R. Atterson and R. L. Hamlin

    Version of Record online : 27 JAN 2015, DOI: 10.1111/jvp.12203

  11. Pharmacokinetics and Pharmacodynamics of Multiple Sublingual Buprenorphine Tablets in Dose-Escalation Trials

    The Journal of Clinical Pharmacology

    Volume 46, Issue 2, February 2006, Pages: 179–192, Dr Domenic A. Ciraulo, Dr Robert J. Hitzemann, Dr Eugene Somoza, Dr Clifford M. Knapp, Dr John Rotrosen, Dr Ofra Sarid-Segal, Ms Ann Marie Ciraulo, Dr David J. Greenblatt and Dr C. Nora Chiang

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270005284192

  12. Pharmacokinetics of oral transmucosal and intramuscular dexmedetomidine combined with buprenorphine in cats

    Journal of Veterinary Pharmacology and Therapeutics

    Volume 38, Issue 2, April 2015, Pages: 203–208, N. Porters, H. de Rooster, T. Bosmans, K. Baert, M. Cherlet, S. Croubels, P. De Backer and I. Polis

    Version of Record online : 30 SEP 2014, DOI: 10.1111/jvp.12172

  13. The clinical use of buprenorphine in opiate addiction: evidence and practice

    Acta Neuropsychiatrica

    Volume 16, Issue 5, October 2004, Pages: 246–274, Fergus D. Law, Judy S. Myles, Mark R. C. Daglish and David J. Nutt

    Version of Record online : 11 FEB 2005, DOI: 10.1111/j.0924-2708.2004.00095.x

  14. Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties

    The Milbank Quarterly

    Volume 93, Issue 3, September 2015, Pages: 561–583, BRADLEY D. STEIN, ROSALIE LICCARDO PACULA, ADAM J. GORDON, RACHEL M. BURNS, DOUGLAS L. LESLIE, MARK J. SORBERO, SEBASTIAN BAUHOFF, TODD W. MANDELL and ANDREW W. DICK

    Version of Record online : 8 SEP 2015, DOI: 10.1111/1468-0009.12137

  15. You have free access to this content
    Buprenorphine: An Analgesic with an Expanding Role in the Treatment of Opioid Addiction

    CNS Drug Reviews

    Volume 8, Issue 4, December 2002, Pages: 377–390, Susan E. Robinson

    Version of Record online : 7 JUN 2006, DOI: 10.1111/j.1527-3458.2002.tb00235.x

  16. You have free access to this content
    Post-marketing Surveillance of Methadone and Buprenorphine in the United States

    Pain Medicine

    Volume 11, Issue 7, July 2010, Pages: 1078–1091, Nabarun Dasgupta, Elise J. Bailey, Theodore Cicero, James Inciardi, Mark Parrino, Andrew Rosenblum and Richard C. Dart

    Version of Record online : 8 JUN 2010, DOI: 10.1111/j.1526-4637.2010.00877.x

  17. Abuse potential of intranasal buprenorphine versus buprenorphine/naloxone in buprenorphine-maintained heroin users

    Addiction Biology

    Volume 20, Issue 4, July 2015, Pages: 784–798, Jermaine D. Jones, Maria A. Sullivan, Suzanne K. Vosburg, Jeanne M. Manubay, Shanthi Mogali, Verena Metz and Sandra D. Comer

    Version of Record online : 24 JUL 2014, DOI: 10.1111/adb.12163

  18. Pharmacokinetics of buprenorphine following intravenous and intramuscular administration in male rhesus macaques (Macaca mulatta)

    Journal of Veterinary Pharmacology and Therapeutics

    Volume 37, Issue 5, October 2014, Pages: 480–485, K. R. Kelly, B. H. Pypendop and K. L. Christe

    Version of Record online : 25 MAR 2014, DOI: 10.1111/jvp.12113

  19. Buprenorphine in Maintenance Treatment: Experience among Italian Physicians in Drug Addiction Centers

    The American Journal on Addictions

    Volume 19, Issue 3, May-June 2010, Pages: 222–230, Gianluca Quaglio, Cristian Pattaro, Gilberto Gerra, Paolo Mezzelani, Linda Montanari, Don C. Des Jarlais and Fabio Lugoboni

    Version of Record online : 2 APR 2010, DOI: 10.1111/j.1521-0391.2010.00040.x

  20. Conversion from High-Dose Full-Opioid Agonists to Sublingual Buprenorphine Reduces Pain Scores and Improves Quality of Life for Chronic Pain Patients

    Pain Medicine

    Volume 15, Issue 12, December 2014, Pages: 2087–2094, Danielle Daitch, Jonathan Daitch, Daniel Novinson, Michael Frey, Carol Mitnick and Joseph Pergolizzi Jr

    Version of Record online : 12 SEP 2014, DOI: 10.1111/pme.12520